Whilst there has been no previous detailed quantitative assessment of muscle development in secondary dystroglycanopathy mice, other work has suggested that the severity of the phenotype may correlate with when the expression of genes, such as that encoding for fukutin, are deleted [35, 51]. Here, FKTN is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.